drugset / Trial / NCT06665425
PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
A Phase 1 Study to evaluate the safety, PK/PD, drug-drug interaction(DDI) of Epaminurad and C2406 in Healthy Volunteers
Timeline
- Start
- 2025-03-24
- Primary completion
- 2025-05-02
- Completion
- 2025-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C2406 | Unknown | 0.6 mg | — |
| Subject | Epaminurad | Small molecule | 9 mg | — |
Indications
No indication recorded.